YOKOM, Daniel W. et al. Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. Canadian Urological Association Journal, [S. l.], v. 12, n. 8, 2018. DOI: 10.5489/cuaj.5108. Disponível em: https://cuaj.ca/index.php/journal/article/view/5108. Acesso em: 26 apr. 2026.